Anosmia. Anosmia
Conditions
Interventions
Intervention 1: Intervention group: Inhaled Corticosteroid spray (0.05% Mometasone) twice daily for 4 weeks. Intervention 2: Control group: sodium chloride spray (0.65%) twice daily for 4 weeks.
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with COVID-19 who have been referred or admitted to Qaem, Imam Reza, or Shariati Hospital diagnosed with a protocol defined by the World Health Organization. People who have not experienced any signs of reduced sense of smell and taste for at least 2 weeks before the onset of the first manifestation of Covid-19. People who were diagnosed with hyposmia or anosmia.
Exclusion criteria
Exclusion criteria: People with certain underlying conditions (such as Parkinson's, Alzheimer's, severe nutritional disorders, acute rhinitis, acute catarrhal sinusitis, SICA syndrome (especially after radiation), nasal mucosal congestion, for example after rhinoplasty, olfactory nerve damage in trauma, etc., which are exposed to the reduction of the sense of smell independent of the coronavirus, as well as, people who experience other viral and bacterial infections simultaneously with COVID-19 People with a history of asthma and allergies are excluded Participants who refused to participate in follow-up measurements, provide data, or give consent considered withdrawn.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Smell Sense. Timepoint: Time intervals: one week, two weeks, and one month after the intervention. Method of measurement: By VAS test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMasoumeh Hosseinpour
Mashhad University of Medical Sciences
Outcome results
None listed